The ASPIRE project kick-off meeting was held on 28 February 2025.
The ASPIRE-AECC Project «Neoadjuvant and adjuvant therapies to improve survival of HCC» will investigate, in a large 15-hospital clinical trial, whether the combined administration of two immunotherapies, both before and after tumour removal, increases disease-free survival in patients with hepatocellular carcinoma.
ASPIRE-AECC Team